Smoking Cessation in Groups and With Tobacco Pastils

Summary

The purpose of this trial is to examine if smokeless tobacco combined with group support might increase smoking cessation rate compared with groups support in smokers.

Timeline

Start

2005-03

Primary completion

—

Completion

2006-11

Outcome

Missed primary endpoint

paper The primary outcomes (i.e., 6-month point prevalence) were 23.1% versus 20.8%, respectively (OR = 1.31, ns). PMID 18686184 ↗

Publications

• Results Tonnesen P, Mikkelsen K, Bremann L. Smoking cessation with smokeless tobacco and group therapy: an open, randomized, controlled trial. Nicotine Tob Res. 2008 Aug;10(8):1365-72. doi: 10.1080/14622200802238969.

Drugs

Indications

No indication recorded.